🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Bolton Medical clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our USA register with Bolton Medical as lead sponsor. Synced 26 Sep 2026
7Current trials
1Recruiting now
0Drugs in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Bolton Medical is the lead sponsor of 7 current clinical trials in our USA register. 1 is recruiting patients now. All registered phases are Not applicable. The most-studied condition is Aortic Aneurysm, Thoracic.

ClinicalTrials.gov trials by status

  • Recruiting114%
  • Active, closed686%

Trials by phase

  • Not applicable7100%
01

Clinical trials sponsored by Bolton Medical

7 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Endovascular Repair With Fenestrated TREO Stent-Graft System in AAA
NCT07026877 · ClinicalTrials.gov ↗ · Abdominal Aortic Aneurysms (AAA)
Not applicable Recruiting 2025-11 USA
RelayPro Thoracic Stent-Graft in Subjects With Thoracic Aortic Aneurysms and Penetrating Atherosclerotic Ulcers
NCT02818972 · Aortic Aneurysm, Thoracic, Penetrating Ulcer
Not applicable Active, closed 2017-05 USA
Clinical Study of the Treovance Stent-Graft for Patients With Abdominal Aortic Aneurysms
NCT02009644 · Abdominal Aortic Aneurysm (AAA)
Not applicable Active, closed 2013-11 USA
Post-Approval Study of the TREO Abdominal Stent-Graft System
NCT04697784 · ClinicalTrials.gov ↗ · Abdominal Aortic Aneurysm
Not applicable Active, closed 2021-01 USA
Early Feasibility Study of the RelayBranch Thoracic Stent-Graft System
NCT03214601 · ClinicalTrials.gov ↗ · Thoracic Aorta Aneurysm, Aneurysm, Ruptured, Aortic Aneurysm
Not applicable Active, closed 2017-12 USA
Study of the Relay Pro® Thoracic Stent-Graft in Subjects With Traumatic Injury of the Descending Thoracic Aorta
NCT03090230 · ClinicalTrials.gov ↗ · Other Specified Injury of Thoracic Aorta
Not applicable Active, closed 2017-04 USA
Study of the RelayPro Thoracic Stent-Graft in Subjects With an Acute, Complicated Type B Aortic Dissection
NCT03033043 · ClinicalTrials.gov ↗ · Aortic Dissection Type B
Not applicable Active, closed 2017-12 USA

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Bolton Medical trials

10 conditions
Aortic Aneurysm, Thoracic1Penetrating Ulcer1Abdominal Aortic Aneurysm (AAA)1Abdominal Aortic Aneurysm1Thoracic Aorta Aneurysm1Aneurysm, Ruptured1Aortic Aneurysm1Other Specified Injury of Thoracic Aorta1Aortic Dissection Type B1Abdominal Aortic Aneurysms (AAA)1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in USA71

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Aortic Aneurysm, Thoracic

SponsorTrials
W.L.Gore & Associates3

Sponsors with the most current trials registered for this condition.

05

Questions about Bolton Medical trials

How many clinical trials does Bolton Medical sponsor?

Bolton Medical is the lead sponsor of 7 current trials on ClinicalTrials.gov in our USA register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Bolton Medical trials recruiting?

Yes. 1 of its 7 ClinicalTrials.gov trials is recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.